Pharmafile Logo
Pharmafocus logo
Advanced Search

Pope Woodhead re-signed for Abilify account

March 10, 2005
Medical Communications

Bristol-Myers Squibb and Otsuka Pharmaceuticals have renewed Pope Woodhead's contract to provide PR support for Abilify, their antipsychotic treatment for …

News

Diabetes patient cured in UK transplant breakthrough

March 10, 2005
Research and Development

A 61-year-old man from Kent has become one of the first ever patients to be cured of type I diabetes …

News

Pharma’s verdict on e-marketing

March 10, 2005
Sales and Marketing

Feature

Seroquel shows promise in Alzheimer’s

March 9, 2005
Sales and Marketing

New data shows AstraZeneca's blockbuster drug Seroquel to be effective in reducing agitation in elderly patients with Alzheimer's disease (AD).Seroquel …

News

Plans for more independent prescribing progressing

March 9, 2005

Nurses could soon be able to independently prescribe for long-term conditions such as asthma and diabetes, under proposals being considered …

News

SSRI guidance unchanged, says MHRA

March 9, 2005
Sales and Marketing

UK regulator the MHRA has reiterated its guidance on SSRI antidepressants and stressed their safety after a new article linked …

News

Judge us on NHS record, says angry Blair

March 9, 2005

A row over a pensioner's repeatedly cancelled shoulder operation has escalated into a key election battle on the state of …

News

NHS Alliance warns of Health Check

March 9, 2005

The NHS Alliance has warned that the planned replacement to the controversial star ratings performance indicators may lead to 'perverse …

News

Heart progress trumpeted by Labour

March 9, 2005

The government has trumpeted its progress on tackling the UK's biggest killer, cardiovascular disease, and launched a new chapter of …

News

Potential blockbuster Tysabri pulled after patient death

March 9, 2005
Sales and Marketing

Elan and Biogen Idec have stopped marketing Tysabri (natalizumab), their new multiple sclerosis treatment, and asked doctors not to prescribe …

News

ABPI to oppose strictest measures in pan-European code of practice

March 3, 2005
Sales and Marketing

A pan-European code of practice is being drawn up by the pharmaceutical industry organisation EFPIA in response to continuing criticism …

News

GSK rebrands AIDS drugs to foil illegal imports

March 2, 2005
Sales and Marketing

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.The company said parallel importers …

News

Quicker service for cancer patients but ‘black spots’ persist

March 2, 2005

Cancer patients are being seen more quickly but there is still room for improvement, says a National Audit Office report …

News

NICE acts to speed lung cancer diagnosis and treatment

March 2, 2005

Patients showing symptoms of lung cancer should be offered an urgent referral to a chest physician, according to NICE recommendations …

News

Singulair gains dual asthma-hayfever indication

March 2, 2005
Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …

News

NICE U-turn will ‘set Alzheimer’s treatment back 10 years’

March 2, 2005

News

NHS is behind us, says rep-free Takeda

March 1, 2005
Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …

News

Cymbalta approved for second indication

February 24, 2005
Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …

News

Reassessing medical communications

February 24, 2005

It's time to be less defensive about perfectly legitimate medical communications methods providing contentious 'sharp practices' can be consigned to …

Feature

Private sector involvement in NHS continues to grow

February 24, 2005

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026